EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

iPSC-derived cells for whole liver bioengineering

Kayque Alves Telles-Silva, Lara Pacheco, Fernanda Chianca, Sabrina Komatsu, Caroline Chiovatto, Mayana Zatz, Ernesto Goulart

Frontiers in Bioengineering and Biotechnology · 07.02.2024 · 12

DOI: 10.3389/fbioe.2024.1338762 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 07.02.2024. Verfasst von Kayque Alves Telles-Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Human Genome and Stem-Cell Research Center (HUG-CEL), Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver bioengineering stands as a prominent alternative to conventional hepatic transplantation. Through liver decellularization and/or bioprinting, researchers can generate acellular scaffolds to overcome immune rejection, genetic manipulation, and ethical concerns that often accompany traditional transplantation methods, in vivo regeneration, and xenotransplantation. Hepatic cell lines derived from induced pluripotent stem cells (iPSCs) can repopulate decellularized and bioprinted scaffolds, producing an increasingly functional organ potentially suitable for autologous use. In this mini-review, we overview recent advancements in vitro hepatocyte differentiation protocols, shedding light on their pivotal role in liver recellularization and bioprinting, thereby offering a novel source for hepatic transplantation. Finally, we identify future directions for liver bioengineering research that may allow the implementation of these systems for diverse applications, including drug screening and liver disease modeling.

Schlagwörter

Stichwörter der Autor:innen

bioengineeringbioprintingdecellularizationhuman induced pluripotent stem cellsliver

Autor:innen und Institutionen

  • Human Genome and Stem-Cell Research Center (HUG-CEL), Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil.
  • Department of Pharmaceutical Chemistry, Small Molecule Discovery Center, Genentech Hall, University of California, San Francisco, San Francisco, CA, United States.

Zitieren

APA

Telles-Silva, K. A., Pacheco, L., Chianca, F., Komatsu, S., Chiovatto, C., Zatz, M., & Goulart, E. (2024). iPSC-derived cells for whole liver bioengineering. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1338762

Vancouver

Telles-Silva KA, Pacheco L, Chianca F, Komatsu S, Chiovatto C, Zatz M, et al. iPSC-derived cells for whole liver bioengineering. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1338762

BibTeX
@article{TellesSilva2024,
  author = {Telles-Silva, Kayque Alves and Pacheco, Lara and Chianca, Fernanda and Komatsu, Sabrina and Chiovatto, Caroline and Zatz, Mayana and Goulart, Ernesto},
  title = {iPSC-derived cells for whole liver bioengineering},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fbioe.2024.1338762}
}
Kostenlos starten →